Is InfuSystem Holdings, Inc. (INFU) Overvalued?
We dive into why InfuSystem Holdings, Inc. (INFU) could be considered overvalued on 2026-08-18, based on AAII’s Value Score and Grade.Jenna Brashear
Stock Evaluator: InfuSystem Holdings, Inc. (INFU)
InfuSystem Holdings, Inc. INFU
$12.21
0.01
0.08%
August 21, 2026 4:00:00 PM
EST
Volume: 99,979
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
AMEX | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Commentary & Analysis
Why InfuSystem Holdings, Inc.’s (INFU) Stock Is Up 25.60%
As of Tuesday, August 04, InfuSystem Holdings, Inc.’s INFU share price has surged by 25.60%, which has investors questioning if this is right time to sell.Jenna Brashear
Why InfuSystem Holdings, Inc.’s (INFU) Stock Is Up 16.81%
As of Tuesday, August 04, InfuSystem Holdings, Inc.’s INFU share price has surged by 16.81%, which has investors questioning if this is right time to sell.Michael Rose
Why InfuSystem Holdings, Inc.’s (INFU) Stock Is Up 6.80%
As of Tuesday, May 19, InfuSystem Holdings, Inc.’s INFU share price has surged by 6.80%, which has investors questioning if this is right time to sell.Jenna Brashear
Why InfuSystem Holdings, Inc.’s (INFU) Stock Is Down 13.81%
As of Thursday, May 07, InfuSystem Holdings, Inc.’s INFU share price has dipped by 13.81%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | INFU | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $243.2 | $1,968.0 | 29% |
|
| Shares Out (Mil) | 20.9 | 77.7 | 31% |
|
| Institutional Ownership | 91.8% | 86.6% | 60% |
|
| Float (Mil) | 18.4 | 52.1 | 28% |
|
| Beta | 1.46 | 0.75 | 82% |
|
| Avg Daily Volume (000s) | 114 | 612 | 36% |
|
| Price Change (52-week) |
27.2% | 79.8% | 66% |
|
| Growth | INFU | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.2% | 10.9% | 51% |
|
| Net Income (5yr) | (17.5%) | (1.6%) | 23% |
|
| EPS (5yr) | (17.3%) | 0.3% | 16 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.0%) | (17.9%) | 38% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | $0.072 | $0.290 | $0.430 | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (52.0%) | (6.5%) | 80.6% | |
| Financials | INFU | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $143 | $1,504 | 29% |
|
| Net Income (TTM) (Mil) | $9 | $28 | 45% |
|
| EPS (TTM) | $0.422 | $0.200 | 52% |
|
| Operating Cash Flow (TTM) (Mil) | $23 | $162 | 42% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $9 | 44% |
|
| Long-Term Debt (Q1) (Mil) | $23 | $338 | 34% |
|
| Enterprise Value (Q1) (Mil) | $265 | $2,416 | 29% |
|
| Valuation | INFU | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.11 | 2.82 | 73% |
|
| P/E | 30.4 | 26.0 | 69% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | INFU | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 57.5% | 27.8% | 70% |
|
| Net Margin | 6.0% | 1.2% | 51% |
|
| ROA | 8.6% | 2.2% | 84% |
|
| ROE | 15.0% | 7.2% | 71% |
|
| Liabilities to Assets | 39.5% | 58.6% | 30% |
|
| F-Score | 9 | 5 | 98% |
|
Passing Stock Screens
As of 8/21/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Value on the Move--PEG With Est Growth Screen
Factors: Value, Quality, Momentum, Growth
Using PEG ratios and price strength to find growth stocks trading at a reasonable price.
| Performance Since Inception: | 15.8% |
| +/- S&P 500: | +8.3 |
